Кардиопротективный эффект различных технологий анестезии при операциях с искусственным кровообращением

Мельников Николай Юрьевич, Vladimir Viktorovich Pichugin, Бричкин Юрий Дмитриевич et al. · Medical Almanac · 2013

The authors suggest the technology of total myocardial protection with sevoflurane (TMPS) in case of operations with artificial circulation of patients with initially low functional reserves of myocardium. This method included the technology VIMA in combination with permanent coronary perfusion of myocardium with “sevoflurane-containing” perfusate. Materials and methods. Since 2011, June till 2012, May there were performed 30 operations for patients of high risk group with the use of the given technology. There was carried out the comparative assessment of patients of 3 groups: the first group (30 patients) had sevoflurane as the main anesthetic, permanent coronary perfusion of myocardium with “sevoflurane-containing” perfusate (technology TMPS) was used for protection of myocardium; the second group (12 patients) had propofol as the main anesthetic, and as the method for myocardial protection there was used pharmacohypothermal cardioplegia “Konsolom”; the third group (11 patients) had sevoflurane as the main anesthetic, and as the method for myocardial protection there was used crystalloid cardioplegia “Konsolom”. Results. The clinical analysis of the course of restorative and postperfusion period showed the prevalence of number of cases of independent restoration of cardiac activity, and also the decrease of the requirement and dosage of catecholamines at the end of operative intervention of patients of the examined group, which by implication proves better myocardial protection of these patients. The examination of contractive function of myocardium in postperfusion period showed much higher pointers of impact index, acceleration and peak rate of bloodflow against background of lower general peripheral resistance of patients of the group with the use of technology TMPS. The examination of the activity of enzymes ALAT and ASAT showed their increase in the first day after operation with the further decrease of the level in the 2 nd day, moreover the patients of the 1 st group had a lower growth of postoperative activity of these enzymes and their faster normalization after operation. The changes of the activity of the marker of myocardial injury – isoenzyme MB-CPK, were characterized, firstly, by its much lower release into blood just after an operation and, secondly, by its faster normalization (after 24 hours after operation) with the patients of the examined group. 12 out of 30 patients (40%) of the first group (TMPS technology) underwent early activation and were extubated in operation room after 47,0±10,4 minutes. Conclusion. The technology of total myocardial protection with sevoflurane leads to a favorable type of restoration of cardiac activity after ischemia, gives high indices of contractive function of myocardium in postperfusion period, provides with lower release of the marker of myocardial injury – MB-CPK in postoperative period.

Cited by 0 works.

Authors